56 related articles for article (PubMed ID: 9163609)
1. Sodium butyrate induces P53-independent, Fas-mediated apoptosis in MCF-7 human breast cancer cells.
Chopin V; Toillon RA; Jouy N; Le Bourhis X
Br J Pharmacol; 2002 Jan; 135(1):79-86. PubMed ID: 11786482
[TBL] [Abstract][Full Text] [Related]
2. FLIP is constitutively hyperexpressed in Fas-resistant U266 myeloma cells, but is not induced by IL-6 in Fas-sensitive RPM18226 cells.
Kim DK; Cho ES; Yoo JH; Um HD
Mol Cells; 2000 Oct; 10(5):552-6. PubMed ID: 11101147
[TBL] [Abstract][Full Text] [Related]
3. A p53 score derived from TP53 CRISPR/Cas9 HMCLs predicts survival and reveals a major role of BAX in the response to BH3 mimetics.
Durand R; Descamps G; Bellanger C; Dousset C; Maïga S; Alberge JB; Derrien J; Cruard J; Minvielle S; Lilli NL; Godon C; Le Bris Y; Tessoulin B; Amiot M; Gomez-Bougie P; Touzeau C; Moreau P; Chiron D; Moreau-Aubry A; Pellat-Deceunynck C
Blood; 2024 Mar; 143(13):1242-1258. PubMed ID: 38096363
[TBL] [Abstract][Full Text] [Related]
4. Mature dendritic cells are protected from Fas/CD95-mediated apoptosis by upregulation of Bcl-X(L).
Lundqvist A; Nagata T; Kiessling R; Pisa P
Cancer Immunol Immunother; 2002 May; 51(3):139-44. PubMed ID: 11941452
[TBL] [Abstract][Full Text] [Related]
5. The protein expression of Bcl-2, Bax, Fas/Apo-1 in acute myeloid leukemia.
Zhou J; Chen Y; Li C; Liu W
J Tongji Med Univ; 1998; 18(1):42-5. PubMed ID: 10806802
[TBL] [Abstract][Full Text] [Related]
6. Immunochemotherapy of malignant glioma: synergistic activity of CD95 ligand and chemotherapeutics.
Roth W; Fontana A; Trepel M; Reed JC; Dichgans J; Weller M
Cancer Immunol Immunother; 1997 Mar; 44(1):55-63. PubMed ID: 9111585
[TBL] [Abstract][Full Text] [Related]
7. Early and late apoptosis protein expression (Bcl-2, BAX and p53) in traumatic brachial plexus injury.
Suroto H; Asriel A; De Vega B; Samijo SK
J Musculoskelet Neuronal Interact; 2021 Dec; 21(4):528-532. PubMed ID: 34854392
[TBL] [Abstract][Full Text] [Related]
8. NGAL Mediates Anaplastic Thyroid Carcinoma Cells Survival Through FAS/CD95 Inhibition.
Crescenzi E; Mellone S; Gragnano G; Iaccarino A; Leonardi A; Pacifico F
Endocrinology; 2023 Dec; 165(2):. PubMed ID: 38091978
[TBL] [Abstract][Full Text] [Related]
9. T cell apoptosis in human heart allografts: association with lack of co-stimulation?
Van Hoffen E; Van Wichen DF; Leemans JC; Broekhuizen RA; Bruggink AH; De Boer M; De Jonge N; Kirkels H; Slootweg PJ; Gmelig-Meyling FH; De Weger RA
Am J Pathol; 1998 Dec; 153(6):1813-24. PubMed ID: 9846972
[TBL] [Abstract][Full Text] [Related]
10. TP53 function over forms in multiple myeloma.
Neri P; Boise LH
Blood; 2024 Mar; 143(13):1202-1204. PubMed ID: 38546638
[No Abstract] [Full Text] [Related]
11. A career in NMR-An interview with Ad Bax.
Magn Reson Chem; 2023 Jan; 61(1):5-7. PubMed ID: 36136050
[No Abstract] [Full Text] [Related]
12. Correction: A Novel Peptide Derived from Ginger Induces Apoptosis through the Modulation of p53, BAX, and BCL2 Expression in Leukemic Cell Lines.
Chatupheeraphat C; Roytrakul S; Phaonakrop N; Deesrisak K; Krobthong S; Anurathapan U; Tanyong D
Planta Med; 2021 Mar; ():. PubMed ID: 33784770
[No Abstract] [Full Text] [Related]
13. Emerging therapies provide new opportunities to reshape the multifaceted interactions between the immune system and lymphoma cells.
Pizzi M; Boi M; Bertoni F; Inghirami G
Leukemia; 2016 Sep; 30(9):1805-15. PubMed ID: 27389058
[TBL] [Abstract][Full Text] [Related]
14. Strategy to enhance efficacy of doxorubicin in solid tumor cells by methyl-β-cyclodextrin: Involvement of p53 and Fas receptor ligand complex.
Mohammad N; Singh SV; Malvi P; Chaube B; Athavale D; Vanuopadath M; Nair SS; Nair B; Bhat MK
Sci Rep; 2015 Jul; 5():11853. PubMed ID: 26149967
[TBL] [Abstract][Full Text] [Related]
15. Gene expression of anti- and pro-apoptotic proteins in malignant and normal plasma cells.
Jourdan M; Reme T; Goldschmidt H; Fiol G; Pantesco V; De Vos J; Rossi JF; Hose D; Klein B
Br J Haematol; 2009 Apr; 145(1):45-58. PubMed ID: 19183193
[TBL] [Abstract][Full Text] [Related]
16. Complete sequence of p53 gene in 20 patients with lung cancer: comparison with chemosensitivity and immunohistochemistry.
Brattström D; Bergqvist M; Lamberg K; Kraaz W; Scheibenflug L; Gustafsson G; Inganäs M; Wagenius G; Brodin O
Med Oncol; 1998 Dec; 15(4):255-61. PubMed ID: 9951689
[TBL] [Abstract][Full Text] [Related]
17. p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs.
Müller M; Wilder S; Bannasch D; Israeli D; Lehlbach K; Li-Weber M; Friedman SL; Galle PR; Stremmel W; Oren M; Krammer PH
J Exp Med; 1998 Dec; 188(11):2033-45. PubMed ID: 9841917
[TBL] [Abstract][Full Text] [Related]
18. Expression of Apo-1/Fas (CD95), Bcl-2, Bax and Bcl-x in myeloma cell lines: relationship between responsiveness to anti-Fas mab and p53 functional status.
Egle A; Villunger A; Marschitz I; Kos M; Hittmair A; Lukas P; Grünewald K; Greil R
Br J Haematol; 1997 May; 97(2):418-28. PubMed ID: 9163609
[TBL] [Abstract][Full Text] [Related]
19. Expression of apoptosis-related proteins, p53, and DNA fragmentation in sarcomas of the pulmonary artery.
Gaumann A; Tews DS; Mayer E; Dahm M; Petrow PK; Otto M; Kirkpatrick CJ; Kriegsmann J
Cancer; 2001 Sep; 92(5):1237-44. PubMed ID: 11571738
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
